CD200 (OX-2 Membrane Glycoprotein) is Expressed by Follicular T Helper Cells and in Angioimmunoblastic T-cell Lymphoma

被引:42
作者
Dorfman, David M. [1 ,2 ]
Shahsafaei, Aliakbar [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
PD-1; CXCL13; T lymphoblastic leukemia/lymphoma; T-cell prolymphocytic leukemia; peripheral T-cell lymphoma; NOS; anaplastic large cell lymphoma; natural killer/T-cell lymphoma; PROGNOSTIC-FACTOR; PD-1;
D O I
10.1097/PAS.0b013e31820065c9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD200, an immunoglobulin superfamily membrane glycoprotein, is expressed in B cells, a subset of T cells, and in a range of B-cell lymphoproliferative disorders. We recently found, by immunohistochemical staining, that follicular helper T cells associated with neoplastic L and H cells in nodular lymphocyte predominant Hodgkin lymphoma, express CD200. Here we show that CD200 is expressed by follicular helper T cells in reactive lymphoid tissue, using single-color and 2-color immunohistochemical staining. Immunohistochemical staining of a range of T-cell lymphoproliferative disorders shows that the neoplastic cells in angioimmunoblastic T-cell lymphoma are immunoreactive for CD200, and the pattern of expression is similar to that of other follicular helper T-cell markers, PD-1 and CXCL13. In contrast, only a minority of cases of T-cell neoplasms other than angio-immunoblastic T-cell lymphoma are immunoreactive for CD200. A subset of CD200-positive peripheral T-cell lymphoma, not otherwise specified, cases may represent evolving angioimmunoblastic T-cell lymphoma or another neoplasm derived from follicular T helper cells. We conclude that CD200 is a useful immunophenotypic marker of angioimmunoblastic T-cell lymphoma and may be a suitable therapeutic target for an anti-CD200 immunotherapy undergoing clinical trial.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 23 条
[1]   Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates [J].
Brahmer, Julie R. ;
Drake, Charles G. ;
Wollner, Ira ;
Powderly, John D. ;
Picus, Joel ;
Sharfman, William H. ;
Stankevich, Elizabeth ;
Pons, Alice ;
Salay, Theresa M. ;
McMiller, Tracee L. ;
Gilson, Marta M. ;
Wang, Changyu ;
Selby, Mark ;
Taube, Janis M. ;
Anders, Robert ;
Chen, Lieping ;
Korman, Alan J. ;
Pardoll, Drew M. ;
Lowy, Israel ;
Topalian, Suzanne L. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) :3167-3175
[2]   CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells [J].
Brunetti, Lorenzo ;
Di Noto, Rosa ;
Abate, Giovanna ;
Gorrese, Marisa ;
Gravetti, Angela ;
Raia, Maddalena ;
Scalia, Giulia ;
Pascariello, Caterina ;
Camera, Andrea ;
Del Vecchio, Luigi .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (05) :665-667
[3]   T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells [J].
Chtanova, T ;
Tangye, SG ;
Newton, R ;
Frank, N ;
Hodge, MR ;
Rolph, MS ;
Mackay, CR .
JOURNAL OF IMMUNOLOGY, 2004, 173 (01) :68-78
[4]   CD200 (OX-2 Membrane Glycoprotein) Expression in B Cell-Derived Neoplasms [J].
Dorfman, David M. ;
Shahsafaei, Aliakbar .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (05) :726-733
[5]   Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma [J].
Dorfman, DM ;
Brown, JA ;
Shahsafaei, A ;
Freeman, GJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (07) :802-810
[6]   Loss of expression of the WNT/β-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas [J].
Dorfman, DM ;
Greisman, HA ;
Shahsafaei, A .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1539-1544
[7]   Down-regulation of the macrophage lineage through interaction with OX2 (CD200) [J].
Hoek, RM ;
Ruuls, SR ;
Murphy, CA ;
Wright, GJ ;
Goddard, R ;
Zurawski, SM ;
Blom, B ;
Homola, ME ;
Streit, WJ ;
Brown, MH ;
Barclay, AN ;
Sedgwick, JD .
SCIENCE, 2000, 290 (5497) :1768-1771
[8]   Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas [J].
Huang, Yenlin ;
Moreau, Anne ;
Dupuis, Jehan ;
Streubel, Berthold ;
Petit, Barbara ;
Le Gouill, Steven ;
Martin-Garcia, Nadine ;
Copie-Bergman, Christiane ;
Gaillard, Fanny ;
Qubaja, Marwan ;
Fabiani, Bettina ;
Roncador, Giovanna ;
Haioun, Corinne ;
Delfau-Larue, Marie-Helene ;
Marafioti, Teresa ;
Chott, Andreas ;
Gaulard, Philippe .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (05) :682-690
[9]   Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression [J].
Kretz-Rommel, Anke ;
Bowdish, Katherine S. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (01) :5-15
[10]   CD200 expression on tumor cells suppresses antitumor immunity: New approaches to cancer immunotherapy [J].
Kretz-Rommel, Anke ;
Qin, Fenghua ;
Dakappagari, Naveen ;
Ravey, E. Prenn ;
McWhirter, John ;
Oltean, Daniela ;
Frederickson, Shana ;
Maruyama, Toshiaki ;
Wild, Martha A. ;
Nolan, Mary-Jean ;
Wu, Dayang ;
Springhorn, Jeremy ;
Bowdish, Katherine S. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (09) :5595-5605